Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2174/1389557520666201027160833 http://scihub22266oqcxt.onion/10.2174/1389557520666201027160833 33109047!?!33109047 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33109047&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Mini+Rev+Med+Chem 2021 ; 21 (3): 268-272 Nephropedia Template TP {{tp|p=33109047|t=2021. Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19 |pdf=|usr=}}{{33109047}} gab.com Text Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19 JO: Mini Rev Med Chem http://www.kidney.de/pget.php?&tw=1&pmid=33109047 #FOAvip Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndromerelated coronavirus-2 (SARS-CoV-2), has become an ongoing pandemic worldwide. However, there are no vaccines or antiviral drugs with proven clinical efficacy. Therefore, a remedial measure is urgently needed to combat the devastating COVID-19. The pharmacological activities of Nacetylcysteine (NAC) and its potential functions in inhibiting the progression of COVID-19 make it a promising therapeutic agent for the infection. In this mini-review, we discussed the therapeutic potential of NAC in COVID-19 from the perspective of its multisite pharmacological actions. Twit Text FOAVip Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19 ????Mini Rev Med Chem http://www.kidney.de/pget.php?&tw=1&pmid=33109047 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33109047 #FOAvip English Wikipedia <ref>{{Cite pmid|33109047}}</ref> Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19 #MMPMID33109047 Luo P; Liu Y; Liu D; Li J Mini Rev Med Chem 2021[]; 21 (3): 268-272 PMID33109047show ga Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndromerelated coronavirus-2 (SARS-CoV-2), has become an ongoing pandemic worldwide. However, there are no vaccines or antiviral drugs with proven clinical efficacy. Therefore, a remedial measure is urgently needed to combat the devastating COVID-19. The pharmacological activities of Nacetylcysteine (NAC) and its potential functions in inhibiting the progression of COVID-19 make it a promising therapeutic agent for the infection. In this mini-review, we discussed the therapeutic potential of NAC in COVID-19 from the perspective of its multisite pharmacological actions. |*COVID-19 Drug Treatment[MESH] |Acetylcysteine/*pharmacology[MESH] |Antiviral Agents/*pharmacology[MESH] |COVID-19/complications[MESH] |Drug Design[MESH] |Drug Repositioning[MESH] |Humans[MESH] |Nitric Oxide/metabolism[MESH] |Reactive Oxygen Species/metabolism[MESH]Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Tr(epmc).pdf DeepDyve Pubget Overpricing